The coronavirus disease 2019 (COVID-19) pandemic is a challenge for intensive care units (ICUs)
worldwide because of the large numbers of patients, a scarcity of resources, the poor …

Description: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease
with an estimated prevalence of 1 in 5000 that is characterized by the presence of vascular …

Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity
and mortality. There have been many advances in the field of PE in the last few years, …

Background Integrating newly developed tests and treatments for severe pulmonary embolism
(PE) into clinical care requires coordinated multispecialty collaboration. To meet this need…

Multidisciplinary pulmonary embolism response teams (PERTs) are being implemented to
improve care of patients with life-threatening PE. We sought to determine how the creation of …

Hereditary hemorrhagic telangiectasia (HHT, Osler-Weber-Rendu disease) is a rare multisystem
vascular disorder that causes chronic gastrointestinal bleeding, epistaxis, and severe …

Background Inhaled nitric oxide (NO) is a selective pulmonary vasodilator. In-vitro studies
report that NO donors can inhibit replication of SARS-CoV-2. This multicenter study evaluated …

Introduction Data describing safety and tolerability of anticoagulation and antiplatelet
therapy in hereditary hemorrhagic telangiectasia (HHT), the second-most-common inherited …

Background: Health disparities have a major impact in the quality of life and clinical care
received by minorities in the United States. Pulmonary arterial hypertension (PAH) is a rare …

Obstructive sleep apnea (OSA), characterized by intermittent hypoxia (IH) during transient
cessation of breathing, triples the risk for cardiovascular diseases. We used a phage display …